Forum Markets, Inc. (FRMM)
6.00
+0.52
(+9.49%)
USD |
NASDAQ |
Aug 24, 16:00
6.00
0.00 (0.00%)
After-Hours: 20:00
Forum Markets Net Income (Quarterly) : -12.42M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -12.42M |
| March 31, 2026 | -77.53M |
| December 31, 2025 | -231.52M |
| September 30, 2025 | -208.67M |
| June 30, 2025 | -1.346M |
| March 31, 2025 | -1.961M |
| December 31, 2024 | -0.9553M |
| September 30, 2024 | -0.5324M |
| June 30, 2024 | 0.0118M |
| March 31, 2024 | -1.070M |
| December 31, 2023 | -1.227M |
| September 30, 2023 | -10.27M |
| June 30, 2023 | -3.680M |
| Date | Value |
|---|---|
| March 31, 2023 | -4.762M |
| December 31, 2022 | -21.74M |
| September 30, 2022 | -21.49M |
| June 30, 2022 | 2.939M |
| March 31, 2022 | 1.564M |
| December 31, 2021 | 1.036M |
| September 30, 2021 | 18.30M |
| June 30, 2021 | -23.46M |
| March 31, 2021 | -16.20M |
| September 30, 2020 | -0.8294M |
| June 30, 2020 | 0.2674M |
| March 31, 2020 | -2.381M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Abeona Therapeutics, Inc. | -20.19M |
| Corcept Therapeutics, Inc. | 42.14M |
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Anika Therapeutics, Inc. | 3.309M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.365M |
| Total Expenses (Quarterly) | 13.79M |
| EPS Diluted (Quarterly) | -0.7511 |
| Enterprise Value | 94.24M |
| Gross Profit Margin (Quarterly) | -39.41% |
| Profit Margin (Quarterly) | -910.0% |
| Earnings Yield | -553.1% |
| Normalized Earnings Yield | -390.34 |